Term
|
Definition
| phenelzine, tranylcypromine, selegilline |
|
|
Term
|
Definition
| hyperadrenergic crises, hypertensive crises (can't eat anything aged; characterized by severe HTN) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| amitriptyline, imipramine, clomipramine, nortriptyline |
|
|
Term
|
Definition
| orthostatic hypotension, anticholinergic effects, cardiac toxicity, sexual dysfunction, small therapeutic windown |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| venlafaxine (available in XR formulation) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| fluoxetine, citalopram, escitalopram, fluvoxamine, paroxetine, sertraline |
|
|
Term
|
Definition
| fluoxetine (longer wash-out period for MAOI's because of long-lasting metabolite) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| GI upset, headache, neuromuscular restlessness, insomnia, sexual dysfunction |
|
|
Term
|
Definition
|
|
Term
|
Definition
| buproprion (available in SR and XL formulations) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| sedation, but only at low dose; weight gain |
|
|
Term
| name serotonin antagonist and RIs |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| enuresis medical treatment |
|
Definition
|
|
Term
|
Definition
| from abrupt cessation of SSRIs (discontinuation syndrome), common in paroxetine and venlafaxine |
|
|
Term
| use of TCA secondary amines |
|
Definition
| increase norepinephrine; used for sleep problems or neuropathic pain |
|
|
Term
| name TCA secondary amines |
|
Definition
| norepinephrine increase (desipramine, nortryptiline, amoxapine) |
|
|
Term
|
Definition
| serotonin increase (clomipramine, imipramine) |
|
|
Term
|
Definition
| no sexual dysfunction like in SSRIs |
|
|
Term
|
Definition
| lowered seizure threshold |
|
|
Term
| venlafaxine dose-dependent profile |
|
Definition
| pro-serotonergic up to 150mg, pro-noradrenergic 150-300mg |
|
|
Term
| venlafaxine main advantage |
|
Definition
| low protein binding: safe |
|
|
Term
|
Definition
| idiopathich hypertension (CHECK BP) |
|
|
Term
| mirtazapine main advantage |
|
Definition
|
|
Term
|
Definition
| idiopathic hypertension (CHECK BP) |
|
|
Term
| nefazadone main advantage |
|
Definition
|
|
Term
| anti-depressants and increased suicide? |
|
Definition
| yes, but does not make people suicidal; just gives them the motivation to carry out the act |
|
|
Term
|
Definition
| due to SSRIs AND MAOIs, causing too much serotonin; think myoclonus and autonomic instability |
|
|
